Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Iris Veit-Friedrich"'
Autor:
Jörg Fuchs, Bernarda Kazanowska, Iris Veit-Friedrich, Marc Münter, Michael Greulich, Thomas Klingebiel, Thekla von Kalle, Felix Niggli, Stefan S. Bielack, Kirsi Jahnukainen, Gustaf Ljungman, Christian Vokuhl, Monika Sparber-Sauer, Ewa Koscielniak, Sabine Stegmaier, Steffan Loff, Monika Scheer, Ruth Ladenstein
Publikováno v:
Pediatric bloodcancerREFERENCES. 67(2)
BACKGROUND Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft-tissue tumor with benign histologic appearance, though fully malignant behavior is possible. METHODS Patients with LGFMS 5 cm. The best surgical result was resection with free margins (R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c99f2821a447bf0c1a187eb0e16b1c6
https://pubmed.ncbi.nlm.nih.gov/31736251
https://pubmed.ncbi.nlm.nih.gov/31736251
Autor:
Monika Scheer, Thomas Klingebiel, Jörg Faber, Monika Sparber-Sauer, Guido Seitz, Tobias M. Dantonello, Sabine Stegmaier, Stefan S. Bielack, Peter Kaatsch, Christian Vokuhl, Iris Veit-Friedrich, Ewa Koscielniak, Heike Scheithauer
Publikováno v:
Virchows Archiv : an international journal of pathology. 472(3)
The alveolar subtype of rhabdomyosarcoma (RMA) is a strong risk factor. Cases of RMA located in paratesticular sites have however been reported to have similar outcomes to those of embryonal rhabdomyosarcoma (RME). We wanted to re-evaluate the impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23974f8633178019eb6e822eb937c94a
https://pubmed.ncbi.nlm.nih.gov/29468306
https://pubmed.ncbi.nlm.nih.gov/29468306
Autor:
Cooperative Weichteilsarkom Studiengruppe, Tobias M. Dantonello, Stefanie Kube, Bernarda Kazanowska, Thomas Klingebiel, Paul-Gerhardt Schlegel, Gustaf Ljungman, Guido Seitz, Christoph Int-Veen, Iris Veit-Friedrich, Michaela Nathrath, Stefan S. Bielack, Ivo Leuschner, Ewa Koscielniak, Udo Kontny, Ruth Ladenstein, Erika Hallmen, Wolfgang Behnisch, Michael Paulussen, Andreas Schuck
Publikováno v:
Pediatric Blood & Cancer. 60:1267-1273
Recurrences in primary localized alveolar rhabdomyosarcoma (RMA) are common. Post-relapse survival is poor. We evaluated prognostic factors including relapse treatment in patients with recurrent RMA.Relapses occurred in 115/235 patients with nonmetas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fbddba08388468d981842ce1f9b13b3
https://doi.org/10.1002/pbc.24488
https://doi.org/10.1002/pbc.24488
Autor:
Tobias M. Dantonello, Sylvia Kirsch, Stefan S. Bielack, Ivo Leuschner, Bernarda Kazanowska, Ruth Ladenstein, Bernhard F. Schmidt, T. Klingebiel, Thomas Wiebe, Christoph Int-Veen, Joern Treuner, Iris Veit-Friedrich, Helmut Lochbuehler, Felix Niggli, Andreas Schuck, Peter Winkler, Ewa Koscielniak, Erika Hallmen
Publikováno v:
Journal of Clinical Oncology. 26:406-413
Purpose Evaluation of primary tumor-, treatment-, and patient-related factors predicting relapse pattern, risk, and survival after relapse with the aim to design a risk-adapted, tumor-directed surveillance program for patients with localized rhabdomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4640d25e66dadbe567b7aa67e04dad
https://doi.org/10.1200/jco.2007.12.2382
https://doi.org/10.1200/jco.2007.12.2382
Autor:
Erik Sköldenberg, Iris Veit-Friedrich, Thomas Klingebiel, Helmut Lochbühler, Tobias M. Dantonello, Erika Hallmen, Markus Franke, Stefan S. Bielack, Jan Godzinski, Ewa Koscielniak, Andreas Schuck, Gustaf Ljungman, Stefanie Kube, Daniel Kosztyla, R. Wessalowski, Simone Feuchtgruber
Publikováno v:
Annals of surgical oncology. 21(11)
Embryonal rhabdomyosarcoma is the most common pediatric soft tissue sarcoma. The best local treatment in large, nonmetastatic primary unresected nongenitourinary embryonal rhabdomyosarcoma of the abdomen (LARME) is however unclear.We analyzed patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca0d9eb17a6e370cc671fac838c360e9
https://pubmed.ncbi.nlm.nih.gov/25047462
https://pubmed.ncbi.nlm.nih.gov/25047462
Autor:
Tobias M, Dantonello, Christoph, Int-Veen, Andreas, Schuck, Guido, Seitz, Ivo, Leuschner, Michaela, Nathrath, Paul-Gerhardt, Schlegel, Udo, Kontny, Wolfgang, Behnisch, Iris, Veit-Friedrich, Stefanie, Kube, Erika, Hallmen, Bernarda, Kazanowska, Ruth, Ladenstein, Michael, Paulussen, Gustaf, Ljungman, Stefan S, Bielack, T, Klingebiel, E, Koscielniak
Publikováno v:
Pediatric bloodcancer. 60(8)
Recurrences in primary localized alveolar rhabdomyosarcoma (RMA) are common. Post-relapse survival is poor. We evaluated prognostic factors including relapse treatment in patients with recurrent RMA.Relapses occurred in 115/235 patients with nonmetas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::956b6752181be17dbc0641f64ca64e9a
https://pubmed.ncbi.nlm.nih.gov/23418028
https://pubmed.ncbi.nlm.nih.gov/23418028
Autor:
Rupert Handgretinger, Ivo Leuschner, Ruediger Fengler, Stefanie Kube, Daniel Kosztyla, Gustaf Ljungman, Iris Veit-Friedrich, Felix Niggli, Thekla von Kalle, Tobias M. Dantonello, Stefan S. Bielack, Peter Kaatsch, Ewa Koscielniak, Peter Winkler, Thomas Klingebiel
Publikováno v:
Journal of Clinical Oncology. 30:9573-9573
9573 Background: Most patients with pediatric soft tissue sarcoma (PSTS) achieve a 1st remission with primary therapy, but recurrences are frequent and drive mortality. Relapse detection (RD) is the foundation of post-treatment surveillance. The rati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56c752ca52de8044441d78a3dc88ac4e
https://doi.org/10.1200/jco.2012.30.15_suppl.9573
https://doi.org/10.1200/jco.2012.30.15_suppl.9573